Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/159105 |
Resumo: | Multiparticulate systems have biopharmaceutical advantages when compared to the monolithic systems, once they allow different patterns of drug release and can be used in different treatments. The aim of the present work was to develop a biphasic controlled release delivery system, using propranolol hydrochloride (PROP) that can be used for the treatment of circadian diseases. This system was obtained by the combination of cellulosic polymers hydroxypropyl methylcellulose (HPMC) and ethylcellulose (EC) in a 2² factorial experimental design, which allowed the optimization of the development stage. The pellets produced and used in biphasic formulations were evaluated for physical and chemical characteristics and presented acceptable results. The immediate fraction obtained showed the complete release in 30 min while the others kept the release of the drug for 24 h. This study showed that the combination of beads with different releasing characteristics allowed to obtain different release profiles, which can be modulated according to the pathological needs, especially with regard to circadian diseases that suffer alterations throughout the day. |
id |
USP-31_7857c5897454540a850bf8f025c8f9d4 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/159105 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseasesChronotherapyBiphasic ReleasePelletsCellulosic PolymersExperimental DesignMultiparticulate systems have biopharmaceutical advantages when compared to the monolithic systems, once they allow different patterns of drug release and can be used in different treatments. The aim of the present work was to develop a biphasic controlled release delivery system, using propranolol hydrochloride (PROP) that can be used for the treatment of circadian diseases. This system was obtained by the combination of cellulosic polymers hydroxypropyl methylcellulose (HPMC) and ethylcellulose (EC) in a 2² factorial experimental design, which allowed the optimization of the development stage. The pellets produced and used in biphasic formulations were evaluated for physical and chemical characteristics and presented acceptable results. The immediate fraction obtained showed the complete release in 30 min while the others kept the release of the drug for 24 h. This study showed that the combination of beads with different releasing characteristics allowed to obtain different release profiles, which can be modulated according to the pathological needs, especially with regard to circadian diseases that suffer alterations throughout the day.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2018-12-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/15910510.1590/s2175-97902018000417167Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17167Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17167Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e171672175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/159105/154015Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciencesinfo:eu-repo/semantics/openAccessMartins, Sarah MoherdauiMüller, ViniciusGalan, VandersonSouza, Fabio Pinheiro deAndreazza, Itamar FranciscoRosa, Maurício Ferreira da2019-06-24T20:15:38Zoai:revistas.usp.br:article/159105Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-06-24T20:15:38Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases |
title |
Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases |
spellingShingle |
Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases Martins, Sarah Moherdaui Chronotherapy Biphasic Release Pellets Cellulosic Polymers Experimental Design |
title_short |
Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases |
title_full |
Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases |
title_fullStr |
Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases |
title_full_unstemmed |
Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases |
title_sort |
Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases |
author |
Martins, Sarah Moherdaui |
author_facet |
Martins, Sarah Moherdaui Müller, Vinicius Galan, Vanderson Souza, Fabio Pinheiro de Andreazza, Itamar Francisco Rosa, Maurício Ferreira da |
author_role |
author |
author2 |
Müller, Vinicius Galan, Vanderson Souza, Fabio Pinheiro de Andreazza, Itamar Francisco Rosa, Maurício Ferreira da |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Martins, Sarah Moherdaui Müller, Vinicius Galan, Vanderson Souza, Fabio Pinheiro de Andreazza, Itamar Francisco Rosa, Maurício Ferreira da |
dc.subject.por.fl_str_mv |
Chronotherapy Biphasic Release Pellets Cellulosic Polymers Experimental Design |
topic |
Chronotherapy Biphasic Release Pellets Cellulosic Polymers Experimental Design |
description |
Multiparticulate systems have biopharmaceutical advantages when compared to the monolithic systems, once they allow different patterns of drug release and can be used in different treatments. The aim of the present work was to develop a biphasic controlled release delivery system, using propranolol hydrochloride (PROP) that can be used for the treatment of circadian diseases. This system was obtained by the combination of cellulosic polymers hydroxypropyl methylcellulose (HPMC) and ethylcellulose (EC) in a 2² factorial experimental design, which allowed the optimization of the development stage. The pellets produced and used in biphasic formulations were evaluated for physical and chemical characteristics and presented acceptable results. The immediate fraction obtained showed the complete release in 30 min while the others kept the release of the drug for 24 h. This study showed that the combination of beads with different releasing characteristics allowed to obtain different release profiles, which can be modulated according to the pathological needs, especially with regard to circadian diseases that suffer alterations throughout the day. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-12-20 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/159105 10.1590/s2175-97902018000417167 |
url |
https://www.revistas.usp.br/bjps/article/view/159105 |
identifier_str_mv |
10.1590/s2175-97902018000417167 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/159105/154015 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17167 Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17167 Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17167 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222913858633728 |